TOKYO, March 19 (HSMN NewsFeed) — Astellas Pharmaceutical Inc. (TSE:4503.to ) today notified OSI Pharmaceuticals Inc. (Nasdaq:OSIP ) that John D. Gilly, Ph.D. and Margaret T. Monaco will replace Jack Kaye and Heidi L. Steiger on the slate of directors Astellas…
Biopharmaceuticals, Mergers & Acquisitions, Personnel
Astellas Pharmaceutical, OSI Pharmaceuticals

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “Astellas Announces Changes to Director Nominees for Election to OSI Pharmaceuticals’ Board of Directors”
Leave a Comment